DE69811689D1 - Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika - Google Patents

Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika

Info

Publication number
DE69811689D1
DE69811689D1 DE69811689T DE69811689T DE69811689D1 DE 69811689 D1 DE69811689 D1 DE 69811689D1 DE 69811689 T DE69811689 T DE 69811689T DE 69811689 T DE69811689 T DE 69811689T DE 69811689 D1 DE69811689 D1 DE 69811689D1
Authority
DE
Germany
Prior art keywords
4alkyl
hydrogen
4alkyloxy
halo
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811689T
Other languages
English (en)
Other versions
DE69811689T2 (de
Inventor
Johannes Snoeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of DE69811689D1 publication Critical patent/DE69811689D1/de
Publication of DE69811689T2 publication Critical patent/DE69811689T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69811689T 1997-09-18 1998-09-10 Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika Expired - Fee Related DE69811689T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202862 1997-09-18
PCT/EP1998/005751 WO1999013871A2 (en) 1997-09-18 1998-09-10 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents

Publications (2)

Publication Number Publication Date
DE69811689D1 true DE69811689D1 (de) 2003-04-03
DE69811689T2 DE69811689T2 (de) 2003-12-18

Family

ID=8228735

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811689T Expired - Fee Related DE69811689T2 (de) 1997-09-18 1998-09-10 Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika

Country Status (8)

Country Link
US (1) US6544979B1 (de)
EP (1) EP1011726B1 (de)
JP (1) JP3775780B2 (de)
AT (1) ATE233104T1 (de)
AU (1) AU1146099A (de)
DE (1) DE69811689T2 (de)
WO (1) WO1999013871A2 (de)
ZA (1) ZA988527B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586475B1 (en) * 1998-11-20 2003-07-01 Takeda Chemical Industries, Ltd. β-amyloid protein production/secretion inhibitors
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US7476662B2 (en) 2001-06-12 2009-01-13 Janssen Pharmaceutica N.V. Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
KR100967601B1 (ko) 2001-11-23 2010-07-05 얀센 파마슈티카 엔.브이. 두개내압의 상승을 신속히 감소시키기 위한 항-히스타민제의 용도
CA2481855A1 (en) * 2002-04-10 2003-10-23 Ortho-Mcneil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
WO2014087208A2 (en) * 2012-12-06 2014-06-12 Enaltec Labs Pvt. Ltd. A process of preparing alcaftadine
JP2022517316A (ja) 2019-01-11 2022-03-08 ネイジス ファーマシューティカルズ インコーポレイテッド ロイコトリエン合成阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101850A (en) 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
IL101851A (en) 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
KR100251295B1 (ko) * 1992-12-04 2000-05-01 디르크 반테 항앨러지성 이미다조[1,2-a](피롤로, 티에노 또는 푸라노)[2,3-d]아제핀 유도체(Antiallergic imidazo[1,2-a](pyrrolo, thieno or furano)[2,3-d]azepine derivatives)
TW382017B (en) 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
TW527186B (en) * 1996-03-19 2003-04-11 Janssen Pharmaceutica Nv Fused imidazole derivatives as multidrug resistance modulators

Also Published As

Publication number Publication date
WO1999013871A3 (en) 1999-06-03
DE69811689T2 (de) 2003-12-18
JP3775780B2 (ja) 2006-05-17
ZA988527B (en) 2000-03-22
EP1011726B1 (de) 2003-02-26
AU1146099A (en) 1999-04-05
ATE233104T1 (de) 2003-03-15
US6544979B1 (en) 2003-04-08
EP1011726A2 (de) 2000-06-28
WO1999013871A2 (en) 1999-03-25
JP2001516716A (ja) 2001-10-02

Similar Documents

Publication Publication Date Title
TWI268152B (en) 2,4,5-trisubstituted thiazolyl derivatives
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
NO994268D0 (no) Farnesyltransferase-inhiberende 1,8-annelerte kinolinonderivater substituert med N- eller C-bundede imidazoler
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
BR0214164A (pt) Ligantes do receptor canabinóide
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
NO20050073L (no) Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene
ATE410426T1 (de) Heterocyclische verbindungen alsccr5-antagonisten
DE69811689D1 (de) Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
IT1250749B (it) Composti eterociclici ad attivita' a ii antagonista
GEP20084306B (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
DE69930648D1 (de) Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole
CA2302943A1 (en) Phthalazine compounds and therapeutic agents for erectile dysfunction
MX9804426A (es) Derivados de imidazol fusionados como moduladores de la resistencia a los farmacos multiples.
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
ATE339424T1 (de) 3-substituierte 7-alkylidene-3-cephem-4- carbonsäuren als beta-lactamase inhibitoren
TR199902094T2 (xx) 3-Heteroareil-4(3H)-kinazolinonlar�n atropizomerleri.
PT1180094E (pt) Aminoacidos policiclicos fundidos como agentes farmaceuticos
DK0896822T3 (da) 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister
BR0214780A (pt) Sal de ácido cìtrico de um composto terapêutico e composições farmacêuticas deste
NO20033634L (no) GLyT-1-inhibitorer
EE200200215A (et) 2-amino-3,4-dihüdrokinasoliinide kasutamine ravimi valmistamiseks, mis on ette nähtud isheemilistest seisunditest tingitud haiguste raviks või ennetamiseks
DK0974353T3 (da) Anvendelse af homocysteinderivater til behandling af bakterielle infektioner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee